Kim, Nam-Hoon
Lee, Jihyun
Kim, Seung-Hyun
Kang, Seong-Ho
Bae, Sowon
Yu, Chan-Hee
Seo, Jeongmin
Kim, Hun-Taek
Article History
Received: 4 April 2024
Accepted: 8 July 2024
First Online: 6 August 2024
Declarations
:
: The authors have no relevant financial or non-financial interests to disclose.
: Informed consent was obtained from all individual participants included in the study.
: For all experiments involving human or animal subjects, experiments were approved by the appropriate institutional committee prior to execution, and conducted according to the pertinent guidelines and regulations. The animal experiments were approved by the Institutional Animal Care and Use Committee (IACUC) of Chaon Inc. (Gyeonggi-do, Korea) (CE22097, CE21325, CE21256) or Crown Bioscience Inc. (Beijing, China) prior execution. All experiments were conducted according to the pertinent guidelines and regulations implemented by IACUC. The authors complied with the ARRIVE guidelines. All human samples were prospectively obtained under written informed consent. All study protocols were approved by the Institutional Review Board of Tiumbio Co., Ltd (IRB code: TBIRB-22-BR-001).